Medical Developments International (ASX:MVP) Total Debt per Share: A$0.02 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:MVP Medical Developments International Ltd ASX:MVP
51 GF Score
Price A$0.46
GF Value A$0.63
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medical Developments International Total Debt per Share?

Medical Developments International ASX:MVP +1.11% 51 Total Debt per Share is A$0.02 as of Dec. 2025. GuruFocus rates ASX:MVP with a GF Score™ of 51/100 and a GF Value™ of A$0.63 (Modestly Undervalued). The stock has 2 warning signs investors should review.

A$0.02 (As of Dec. 2025)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Medical Developments International's Total Debt Per Share for the quarter that ended in Dec. 2025 was A$0.02.

Medical Developments International Total Debt per Share Related Terms

Medical Developments International Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Medical Developments International's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Developments International Total Debt per Share Chart

Medical Developments International Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.04 0.03 0.03 0.02

Medical Developments International Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.02 0.02 0.02
ASX:MVP
51GF Score
Medical Developments International Ltd ASX:MVP
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Developments International Total Debt per Share Calculation

Medical Developments International's Total Debt Per Share for the fiscal year that ended in Jun. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(1.67+0.32)/112.66
=0.02

Medical Developments International's Total Debt Per Share for the quarter that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(1.50+0.33)/112.66
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of A$0.02 mean?
Medical Developments International (ASX:MVP) has a Total Debt per Share of A$0.02 as of Dec. 2025. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Medical Developments International and its competitors.
Is Medical Developments International's Total Debt per Share too high?
Medical Developments International's current Total Debt per Share is A$0.02. Overall, Medical Developments International has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Developments International's Total Debt per Share compare to ZTS?
Medical Developments International's Total Debt per Share of A$0.02 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Drug Manufacturers company?
A good Total Debt per Share depends on the Drug Manufacturers industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Medical Developments International and its competitors. Medical Developments International's current Total Debt per Share is A$0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Developments International stock overvalued right now?
Based on GuruFocus' analysis, Medical Developments International (ASX:MVP) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.63, compared to a current price of A$0.46 — trading 27.8% below its estimated fair value. The current Total Debt per Share is A$0.02. Medical Developments International's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Medical Developments International (ASX:MVP), the current Total Debt per Share is A$0.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Developments International (ASX:MVP) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Developments International stock appears to be undervalued. The current stock price of A$0.46 is trading 27.8% below its estimated GF Value™ of A$0.63. GuruFocus considers Medical Developments International to be Modestly Undervalued.

Key valuation signals for ASX:MVP:

  • Total Debt per Share: A$0.02
  • GF Value™: A$0.63 vs. price of A$0.46 (27.8% below fair value)
  • GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the ASX:MVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medical Developments International Business Description

Other Exchanges MDDVF:USAM5D:Germany
Address 4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
51GF Score

Get the complete analysis for ASX:MVP

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.46
Price
A$0.63
GF Value